QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
NASDAQ:LFMD

LifeMD (LFMD) Stock Forecast, Price & News

$5.89
+0.39 (+7.09%)
(As of 09/28/2023 ET)
Compare
Today's Range
$5.34
$5.92
50-Day Range
$3.49
$5.50
52-Week Range
$1.14
$5.92
Volume
814,575 shs
Average Volume
253,211 shs
Market Capitalization
$212.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.50

LifeMD MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
27.3% Upside
$7.50 Price Target
Short Interest
Bearish
7.83% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.83mentions of LifeMD in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$350,618 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.65) to ($0.23) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.05 out of 5 stars

Medical Sector

566th out of 969 stocks

Offices & Clinics Of Medical Doctors Industry

3rd out of 6 stocks


LFMD stock logo

About LifeMD (NASDAQ:LFMD) Stock

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including urgent and primary care, men's and women's health, and dermatology, chronic care management, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and food and drug administration approved medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and NavaMD, a female-oriented and tele-dermatology brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. The company sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

LFMD Price History

LFMD Stock News Headlines

LifeMD to Participate in Two Investor Conferences in October
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
As the Market Struggles to Bounce, I'm Watching These 7 Stocks
My Top Small-Cap Pick for a Strong Year-End Run
Bertrand Velge Bought 12% More Shares In LifeMD
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
I've Got a Play for LifeMD as It Gets Its Life Together
Is the July CPI Report Really Good News?
B.Riley Financial Sticks to Its Buy Rating for LifeMD (LFMD)
LifeMD Shares Undervalued: Analyst Initiates With Outperform Rating
B.Riley Financial Reaffirms Their Buy Rating on LifeMD (LFMD)
3 Potential Turnarounds in Small-Cap Stocks to Watch
LifeMD earnings: here's what Wall Street expects
See More Headlines
Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

LFMD Company Calendar

Last Earnings
8/09/2023
Today
9/28/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LFMD
Fax
N/A
Employees
199
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.50
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+27.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-45,540,000.00
Pretax Margin
-21.57%

Debt

Sales & Book Value

Annual Sales
$119.03 million
Book Value
($0.38) per share

Miscellaneous

Free Float
29,226,000
Market Cap
$212.22 million
Optionable
Optionable
Beta
1.69
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Justin SchreiberMr. Justin Schreiber (Age 40)
    Chairman & CEO
    Comp: $255k
  • Mr. Marc Benathen (Age 42)
    Chief Financial Officer
    Comp: $378.75k
  • Mr. Eric H. Yecies (Age 45)
    Chief Compliance Officer, Gen. Counsel & Sec.
    Comp: $332k
  • Mr. Brad Michael Roberts (Age 42)
    Chief Operating Officer
  • Ms. Maria E. Stan CPA (Age 48)
    Controller & Principal Accounting Officer
  • Mr. Dennis Wijnker (Age 47)
    Chief Technology Officer
  • Ms. Jessica Friedeman (Age 39)
    Chief Marketing Officer
  • Mr. Stefan GalluppiMr. Stefan Galluppi (Age 36)
    Chief Innovation Officer
  • Mr. Nicholas P. Alvarez (Age 41)
    Chief Acquisition Officer & Head of Customer Acquisition
  • Mr. Varun Pathak
    Chief Software Engineer & Co-Founder of PDF Simpli













LFMD Stock - Frequently Asked Questions

Should I buy or sell LifeMD stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifeMD in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LFMD shares.
View LFMD analyst ratings
or view top-rated stocks.

What is LifeMD's stock price forecast for 2023?

3 Wall Street analysts have issued twelve-month price objectives for LifeMD's stock. Their LFMD share price forecasts range from $7.00 to $9.00. On average, they predict the company's share price to reach $7.50 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price.
View analysts price targets for LFMD
or view top-rated stocks among Wall Street analysts.

How have LFMD shares performed in 2023?

LifeMD's stock was trading at $1.94 on January 1st, 2023. Since then, LFMD stock has increased by 203.6% and is now trading at $5.89.
View the best growth stocks for 2023 here
.

When is LifeMD's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our LFMD earnings forecast
.

How were LifeMD's earnings last quarter?

LifeMD, Inc. (NASDAQ:LFMD) announced its quarterly earnings data on Wednesday, August, 9th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.14. The business earned $35.95 million during the quarter, compared to analyst estimates of $35.29 million. LifeMD had a negative net margin of 23.30% and a negative trailing twelve-month return on equity of 7,255.81%.

What guidance has LifeMD issued on next quarter's earnings?

LifeMD updated its third quarter 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $37.50 million-$38.50 million, compared to the consensus revenue estimate of $37.31 million.

What is LifeMD's stock symbol?

LifeMD trades on the NASDAQ under the ticker symbol "LFMD."

Who are LifeMD's major shareholders?

LifeMD's stock is owned by many different institutional and retail investors. Top institutional shareholders include Royce & Associates LP (3.15%), B. Riley Financial Inc. (1.43%), BlackRock Inc. (1.19%), Granahan Investment Management LLC (0.85%), Geode Capital Management LLC (0.70%) and Marshall Wace LLP (0.36%). Insiders that own company stock include Bertrand Velge, Brad Michael Roberts, Corey Deutsch, Eric Harold Yecies, Happy David Walters, Joseph Ditrolio, Justin Schreiber, Marc David Benathen, Naveen Bhatia, Nicholas P Alvarez and Stefan Galluppi.
View institutional ownership trends
.

How do I buy shares of LifeMD?

Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LifeMD's stock price today?

One share of LFMD stock can currently be purchased for approximately $5.89.

How much money does LifeMD make?

LifeMD (NASDAQ:LFMD) has a market capitalization of $212.22 million and generates $119.03 million in revenue each year. The company earns $-45,540,000.00 in net income (profit) each year or ($1.04) on an earnings per share basis.

How many employees does LifeMD have?

The company employs 199 workers across the globe.

How can I contact LifeMD?

LifeMD's mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The official website for the company is www.lifemd.com. The company can be reached via phone at (866) 351-5907 or via email at cdeutsch@lifemd.com.

This page (NASDAQ:LFMD) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -